Delivery Order SPE2DB24D2208-SPE2DB24FHGUP

Award Date 6/13/24
Potential Completion Date 6/14/24
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product REPATHA 140 MG/ML SURECLICKML, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The firm-fixed-price delivery order is valued at $22,326.75 and has a completion date of December 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within...
This federal contract award is a Delivery Order valued at $11,534.06 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product, with a period of performance through April 9, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the pharmaceutical product REPATHA 140 MG/ML SURECLICKML, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,103.96 Firm Fixed Price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 5, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award is for the supply of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,069.72 firm fixed-price delivery order was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 10, 2024 and was not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $4,938.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4568108388 REPATHA 140 MG/ML SURECLICKML. The contract is a Firm Fixed Price Delivery Order with a performance period through May 2, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $3,413.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REPATHA 140 MG/ML SURECLICKML, a specialty medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award is for the supply of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $4,677.64. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for the delivery of REPATHA 140 MG/ML SURECLICKML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,840.98 firm fixed-price contract is a delivery order against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The IDC is valued at up to $999,999,999 and is the primary vehicle for AmerisourceBergen to provide a comprehensive range of medical commodities to support military...
This federal contract award is for the supply of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,525.23, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has an ultimate completion date of August 6, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. There is no set-aside designation for this award. Amerisourcebergen holds significant...
This federal contract award, valued at $7,396.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of REPATHA 140 MG/ML SURECLICK, a prescription medication, with a completion date of March 11, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB24D2208
    Indefinite Delivery Contract
  • SPE2DB24D2208-SPE2DB24FHGUP
    Delivery Order

This federal contract award is for the pharmaceutical product REPATHA 140 MG/ML SURECLICK. It was awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,504.85, is a delivery order with a firm fixed price. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 10:12 AM